Quantcast

Europe

Novartis data show early treatment with Mayzent® (siponimod) delays disability progression and show benefits in cognitive performance in patients with secondary progressive multiple sclerosis (SPMS)

Post hoc EXPAND analysis showed improvements in cognitive processing speed in patients with active and non-active SPMS treated with Mayzent1 

Posted in Europe, news | Tagged , | Leave a comment

Gyroscope Therapeutics Announces Initiation of Phase II Programme Evaluating its Investigational Gene Therapy, GT005, for Dry Age-Related Macular Degeneration

Gyroscope doses first patient in Phase II EXPLORE trial evaluating GT005 in people with geographic atrophy secondary to dry AMD with a mutation in the Complement Factor I gene.

Posted in Europe, news | Leave a comment

VarmX Raises €32 Million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants

VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the completion of a €32 million Series B financing round.

Posted in Europe, news | Tagged | Leave a comment

NTG Nordic Transport Group increases the share capital to acquire remaining 15% of the shares in Ebrex Business Solutions Ltd.

NTG Nordic Transport Group increases the share capital to acquire remaining 15% of the shares in Ebrex Business Solutions Ltd.

Posted in Europe, news | Leave a comment

GENFIT: Enhances Board of Directors with Two Strategic Appointments

Lille (France), Cambridge (Massachusetts, United States), July 7, 2020 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated

Posted in Europe, news | Tagged | Leave a comment

Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Phase 3 LIBERTY Studies in Women with Uterine Fibroids and from Ovulation Inhibition Study

Data from Phase 3 LIBERTY program show improvement in patient-reported outcomes in addition to improvement in hemoglobin levels in anemic

Posted in Europe, news | Tagged | Leave a comment

Rentschler Biopharma, Vetter team up to simplify processes and optimize time-to-market

Vetter and Rentschler Biopharma have announced joining forces to boost their services and along the biopharmaceutical value chain.

Posted in Europe, news | Tagged , | Leave a comment

Abivax starts testing ABX464 with older Covid-19 patients

Abivax has treated the first patient in its Phase 2b/3 study of ABX464 in COVID-19 patients at the University Hospital Center in Nice, France (CHU Nice) in a randomized, double-blind, placebo-controlled study, to see the the effects of early treatment in 1034 Covid-19 older or high-risk patients.

Posted in Europe, news | Tagged , , , | Leave a comment

EUSA Pharma gets FDA’s green light for further testing of siltuximab in COVID-19 patients with acute respiratory distress syndrome

EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, received the approval from the U.S. Food & Drug Administration (FDA) for a randomized, double-blind, placebo-controlled Phase 3 clinical trial to test intravenous siltuximab plus standard of care in hospitalized patients with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS).

Posted in Europe, news | Tagged , , | Leave a comment

Bavarian Nordic Announces European Marketing Authorization for Ebola Vaccine

Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the European Commission has granted marketing authorization for MVABEA® (MVA-BN Filo) together with ZABDENO® (Ad26.ZEBOV), which collectively constitute Janssen’s Ebola vaccine regimen. The approval follows a Positive Opinion by the CHMP of the European Medicines Agency (EMA) in May 2020.

Posted in Europe, news | Tagged , , | Leave a comment